GGI
EW icon

GPM Growth Investors’s Edwards Lifesciences EW Stock Holding History

GPM Growth Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,291
Closed -$1.34M – 39
2023
Q3 		$1.34M Sell
19,291
-6,232
-24% -$501K 0.7% 33
2023
Q2 		$2.41M Sell
25,523
-35
-0.1% -$3.04K 1.26% 29
2023
Q1 		$2.11M Sell
25,558
-369
-1% -$29K 1.22% 28
2022
Q4 		$1.93M Sell
25,927
-175
-0.7% -$13.5K 1.17% 30
2022
Q3 		$2.16M Sell
26,102
-67
-0.3% -$6.45K 1.44% 26
2022
Q2 		$2.49M Buy
26,169
+87
+0.3% +$9.01K 1.62% 24
2022
Q1 		$3.07M Buy
+26,082
New +$2.93M 1.69% 24

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

GPM Growth Investors's EW Position: Q4 2023 in Review

GPM Growth Investors sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 19,291 shares — an estimated $1.34M sold.

GPM Growth Investors first reported a position in EW in Q1 2022 and held it in 7 quarters. The position peaked at $3.07M in Q1 2022. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • GPM Growth Investors reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • GPM Growth Investors sold 19,291 Edwards Lifesciences shares in Q4 2023, an estimated $1.34M.
  • GPM Growth Investors first reported a position in Edwards Lifesciences in Q1 2022 and held it in 7 quarters.
  • GPM Growth Investors's Edwards Lifesciences position peaked at $3.07M in Q1 2022.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on GPM Growth Investors's 13F filing for Q4 2023, filed 5 Feb 2024.